<DOC>
	<DOC>NCT01956123</DOC>
	<brief_summary>This trial investigates the immunogenicity of FE 999049 in repeated cycles.</brief_summary>
	<brief_title>Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Informed Consent Documents signed prior to screening evaluations related to this protocol Participation in the pivotal efficacy trial (trial 000004/ESTHER1) AntiFSH antibody results from baseline and at least one postdosing assessment in the previous cycle(s) available. Having undergone the oocyte retrieval procedure, or having had cycle cancellation prior to oocyte retrieval due to poor ovarian response or excessive ovarian response, in the previous cycle(s). Failure to achieve ongoing pregnancy in the previous cycle(s). Noncompliance to protocol compliance in the previous cycle(s). Having undergone any stimulation with gonadotropins since the endoftrial / endofcycle visit in the previous cycle One or more follicles â‰¥10 mm observed on the transvaginal ultrasound prior to start of dosing on stimulation day 1 Severe OHSS in a previous cycle. Any clinically relevant change to any of the eligibility criteria in the previous cycle(s). Clinically relevant medical history since the previous cycle which precludes gonadotropin stimulation or is associated with a reduced chance of pregnancy.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>